.png){kind=logo}
GC Asia
Copying and distributing are prohibited without permission of the publisher.
Rottapharm plans debut high yield bond as step towards IPO
Rottapharm Madaus, an Italian-German pharmaceutical company, is looking to raise €400m in its debut bond issue. The planned notes are senior unsecured, have a 2019 maturity and are callable after three years.
Already a subscriber? Login
05 Nov 2012
-
Latest news from Corporate Bonds
-
GC Podcast: Revised guidance — ECB hunkers down for the long haul
23 Jul 2021 -
Valeo focuses on carbon footprint for debut SLB
23 Jul 2021 -
Shandong Iron and Steel shows strength with new bond
23 Jul 2021 -
Ping An builds deal in green market
23 Jul 2021 -
British Airways brings sustainability-linked EETC
22 Jul 2021
-
-
Latest news from Corporate Bonds
-
GC Podcast: Revised guidance — ECB hunkers down for the long haul
23 Jul 2021 -
Valeo focuses on carbon footprint for debut SLB
23 Jul 2021 -
Shandong Iron and Steel shows strength with new bond
23 Jul 2021 -
Ping An builds deal in green market
23 Jul 2021 -
British Airways brings sustainability-linked EETC
22 Jul 2021
-
